Shenzhen New Industries receives approval for two new reagents

Shenzhen New Industries Biomedical Engineering (SZSE:300832) announced that it has received medical device registration certificates from the Guangdong Provincial Drug Administration for two new in-vitro diagnostic reagents. The approvals cover a Monoamine Oxidase (MAO) assay kit using the glutamate dehydrogenase method, used for the adjunctive diagnosis of liver fibrosis, and an electrolyte test kit, used for the adjunctive diagnosis of potassium, sodium, chlorine and calcium metabolism disorders and lithium poisoning. The company has now received 70 biochemical reagent registration certificates, a total of 104 certificates, which will positively impact the company's development, especially in "liver function" and "inorganic ion" categories.